BioDelivery Sciences International, Inc. (BDSI): Price and Financial Metrics

BioDelivery Sciences International, Inc. (BDSI): $3.54

-0.05 (-1.39%)

POWR Rating

Component Grades













Add BDSI to Watchlist
Sign Up

Industry: Biotech


of 486

in industry


  • Quality is the dimension where BDSI ranks best; there it ranks ahead of 98.42% of US stocks.
  • The strongest trend for BDSI is in Growth, which has been heading down over the past 31 weeks.
  • BDSI's current lowest rank is in the Momentum metric (where it is better than 11.83% of US stocks).

BDSI Stock Summary

  • Of note is the ratio of Biodelivery Sciences International Inc's sales and general administrative expense to its total operating expenses; 86.84% of US stocks have a lower such ratio.
  • With a year-over-year growth in debt of 33.95%, Biodelivery Sciences International Inc's debt growth rate surpasses 81.21% of about US stocks.
  • Over the past twelve months, BDSI has reported earnings growth of 213.21%, putting it ahead of 91.26% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Biodelivery Sciences International Inc, a group of peers worth examining would be ATRS, LRN, VMD, PDEX, and AUDC.
  • BDSI's SEC filings can be seen here. And to visit Biodelivery Sciences International Inc's official web site, go to

BDSI Price Target

For more insight on analysts targets of BDSI, see our BDSI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.96 Average Broker Recommendation 1.43 (Moderate Buy)

BDSI Stock Price Chart Interactive Chart >

Price chart for BDSI

BDSI Price/Volume Stats

Current price $3.54 52-week high $5.45
Prev. close $3.59 52-week low $3.04
Day low $3.53 Volume 67,437
Day high $3.59 Avg. volume 1,026,784
50-day MA $3.50 Dividend yield N/A
200-day MA $3.85 Market Cap 348.88M

BioDelivery Sciences International, Inc. (BDSI) Company Bio

BioDelivery Sciences International, Inc. engages in the development and commercialization of pharmaceutical products principally in the areas of pain management and addiction. The company was founded in 1997 and is based in Raleigh, North Carolina.

BDSI Latest News Stream

Event/Time News Detail
Loading, please wait...

BDSI Latest Social Stream

Loading social stream, please wait...

View Full BDSI Social Stream

Latest BDSI News From Around the Web

Below are the latest news stories about Biodelivery Sciences International Inc that investors may wish to consider to help them evaluate BDSI as an investment opportunity.

Will Weakness in BioDelivery Sciences International, Inc.'s (NASDAQ:BDSI) Stock Prove Temporary Given Strong Fundamentals?

BioDelivery Sciences International (NASDAQ:BDSI) has had a rough three months with its share price down 5.5%. However...

Yahoo | June 20, 2021

BioDelivery Sciences: Clinic-To-Market Transition Problem

Photo by primeimages/E+ via Getty Images BioDelivery Sciences (BDSI) just proved once again my conviction that when emerging biopharma companies morph into commercial companies, they do not do well. I'm not proud of that statement - good medicine should sell well - but that's what it is. I could prove...

Avisol Capital Partners on Seeking Alpha | May 28, 2021

BioDelivery Sciences International (BDSI) Misses Q1 Earnings Estimates

BioDelivery (BDSI) delivered earnings and revenue surprises of -28.57% and 0.07%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 6, 2021

BioDelivery Sciences Reports First Quarter 2021 Results

Total Company Net Revenue of $41 Million, an Increase of 7% versus Prior Year Net Income of $5.2 Million, EBITDA Margin of 22% and Operating Cash Generation of $11 MillionConference Call and Webcast Scheduled for 8:30 AM EST Today RALEIGH, N.C., May 06, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today reported strong financial results for the first quarter ended March 31, 2021, including the following operational and performance highlights. Key Business Highlights Total Company net revenue for the first quarter increased by 7% versus the prior year period to $41.0 million. This growth was driven by BELBUCA® net sales of $36.4 million...

Yahoo | May 6, 2021

BioDelivery Sciences International, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 6, 2021 / BioDelivery Sciences International, Inc. (NASDAQ:BDSI) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 8:30 AM Eastern Time.

Yahoo | May 6, 2021

Read More 'BDSI' Stories Here

BDSI Price Returns

1-mo -1.94%
3-mo 0.28%
6-mo -17.67%
1-year -24.52%
3-year 14.19%
5-year 48.12%
YTD -15.71%
2020 -33.54%
2019 70.81%
2018 25.42%
2017 68.57%
2016 -63.47%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9139 seconds.